TB-500 (ABP-7) 10mg – Premium Research Peptide for Tissue Repair and Regeneration Studies

TB-500 (ABP-7), also known as Actin-Binding Peptide-7 or Ac-LKKTETQ, is a high-purity synthetic heptapeptide that represents the core active actin-binding domain of the naturally occurring protein Thymosin Beta-4 (Tβ4). Offered in a convenient 10mg lyophilized vial, this research peptide is a valuable tool for scientists investigating cellular migration, wound healing, angiogenesis, and tissue regeneration mechanisms.

As interest in regenerative biology continues to grow, TB-500 (ABP-7) has become a focal point in preclinical research due to its targeted action on actin dynamics — a fundamental process in cell structure, movement, and repair. This detailed guide explores the product’s specifications, mechanism of action, research applications, and practical laboratory considerations for researchers exploring tissue repair peptides.

Chemical and Structural Specifications

TB-500 (ABP-7) is a compact, N-acetylated heptapeptide designed for high specificity in laboratory models.

This smaller fragment offers researchers a more precise model compared to the full-length 43-amino-acid Thymosin Beta-4 (molecular weight ~4963 g/mol), allowing focused study of actin-binding effects.

Mechanism of Action

The primary mechanism of TB-500 (ABP-7) involves high-affinity binding to G-actin (globular actin) monomers. By sequestering G-actin, the peptide modulates its polymerization into F-actin filaments, which are essential for cytoskeletal reorganization, cell shape maintenance, and motility.

This actin regulation triggers several downstream processes critical to tissue repair:

• Enhanced cell migration (keratinocytes, fibroblasts, endothelial cells)
• Promotion of angiogenesis (new blood vessel formation)
• Improved wound contraction and extracellular matrix remodeling
• Modulation of inflammatory responses during healing

Because ABP-7 contains the key actin-binding domain of Thymosin Beta-4, many researchers consider it the minimal active sequence responsible for significant regenerative signaling. Studies suggest it may promote faster cell recruitment to injury sites and support more organized tissue remodeling.

Key Research Applications

TB-500 (ABP-7) is extensively studied in preclinical models for its potential role in regenerative medicine. Primary research areas include:

1. Wound Healing and Skin Repair Preclinical investigations show that the peptide may accelerate wound closure, enhance re-epithelialization, and reduce scar formation through improved fibroblast migration and collagen organization.

2. Musculoskeletal and Soft Tissue Recovery Research models involving muscle, tendon, and ligament injuries explore how ABP-7 supports recovery by promoting cell migration and angiogenesis, potentially improving flexibility and reducing downtime in experimental injury settings.

3. Angiogenesis and Vascular Studies The peptide’s ability to stimulate new blood vessel formation makes it a tool for cardiovascular and ischemia-related research, where enhanced nutrient delivery to damaged tissues is critical.

4. Anti-Inflammatory and Immune Modulation Some studies indicate potential modulation of macrophage polarization toward anti-inflammatory phenotypes, supporting a more favorable healing environment.

5. Cellular Biology and Actin Dynamics As a precise probe, ABP-7 is used to dissect cytoskeletal processes in cell culture and in vivo models.

Note: All referenced findings come from in vitro and animal studies. Human clinical data is limited, and TB-500 (ABP-7) is strictly for laboratory research use only.

TB-500 (ABP-7) vs Full-Length Thymosin Beta-4 (TB-500 Variants)

This comparison helps researchers select the most appropriate tool for their specific experimental goals.

Handling, Reconstitution, and Storage Guidelines

For optimal results in laboratory settings: